Ventricular Assist Devices (VAD)

This channel includes news and new technology innovations for ventricular assist devices (VAD). VADs are a type of mechanical hemodynamic support device that helps increase blood flow in people who have ventricles that are not work properly due to heart failure, cardiogenic shock, cardiomyopathy or myocardial infarction. Most often these devices support the left ventricle, so they are often referred to as left ventricular assist devices (LVAD). VADS come in two types, surgically implanted, usually as a bridge to heart transplant, and percutanenous catheter-based pumps used for temporary hemodynamic support. Examples of temporary percutaneous pumps include the Impella and TandemHeart devices.

 

intraaortic balloon pumps, IABP, ventricular assist devices, VAD, cost effective
News | April 09, 2015
April 9, 2015 — Maquet Cardiovascular USA announced publication of a manuscript comparing the clinical and economic...
expert consensus, SCAI, ACC, HFSA, STS, heart pumps, MCS devices

The Abiomed Impella device

Feature | April 07, 2015
April 7, 2015 — An expert consensus statement released by four leading cardiovascular societies provides new guidance...
SynCardia, Total Artificial Heart, 50cc, FDA, investigational study
News | April 02, 2015
April 2, 2015 — SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct an...
Impella, FDA, high risk PCI, abiomed

Abiomed's Impella 2.5 now has an FDA indication for high-risk PCI.

Technology | March 25, 2015
March 24, 2015 – The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) clearance for...
News | January 30, 2015
January 30, 2015 — SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct a...
Thoratec, HeartMate III, VAD, NewYork Presbyterian, trial, ventricular assist

HeartMate III image courtesy of Thoratec

News | January 27, 2015
January 27, 2015 — NewYork-Presbyterian Hospital/Columbia University Medical Center is one of a select group of medical...
News | October 09, 2014
October 9, 2014 — CardiacAssist Inc. announced that the first Protek Duo veno-venous extracorporeal life support (VV...
Feature | October 08, 2014
September 16, 2014 – Clinical trial results by Recover Right revealed a survival rate of 73 percent in the total...
St. Vincent Implant Thoratec Corp. HeartMate III VAD
News | October 06, 2014
October 6, 2014 — St. Vincent Heart Center officials announced that the faith-based hospital is the second in the...
heartmate III, tohratec, heart failure, heart failure treatment

HeartMate III

News | September 29, 2014
September 29, 2014 – Thoratec Corporation announced that it has begun to enroll patients in the HeartMate III U.S....
VADs Gain Popularity Artificial Hearts Remain Ideal GlobalData
Feature | September 22, 2014
September 22, 2014 — Robert Littlefield, MSc, GlobalData's senior analyst covering Medical Devices, said: “Since the...
Technology | September 05, 2014
September 5, 2014 — CardiacAssist announced it has received 510(k) clearance from the U.S. Food and Drug Administration...
News | August 29, 2014
August 29, 2014 — CardiacAssist announced it has received a Class 2 medical device license from Health Canada for its...
MYDICAR Celladon Corp. Clinical Trial Heart Failure Treatments LVADs
News | August 13, 2014
August 13, 2014 — Celladon Corp. announced that the first patient has been dosed in a clinical trial titled "...
SynCardia Total Artificial Heart SynHall Valves FDA approval

SynCardia Systems Inc. received FDA approval to manufacture the SynCardia Total Artificial Heart with SynHall valves. The OK gives the company control over the two critical components for heart manufacturing: The valves and the unique formula for segmented polyurethane solution (SPUS), which is manufactured only by SynCardia.

Technology | August 11, 2014
August 11, 2014 — SynCardia Systems Inc. received approval in July from the U.S. Federal Drug Administration (FDA) for...